Our surgery is taking part in the FLASH study which is investigating
whether a medication called Atuliflapon can improve symptoms for patients living with moderate to severe uncontrolled Asthma.
This study is recruiting male and female participants between the age of 18-55 years of age with a confirmed asthma diagnosis.
If you meet the study criteria, you may receive a text message, email or letter asking whether you would like to take part. Participation is entirely voluntary and you can opt out at any time.
If you have any questions about this study please contact the uMed nurse support team at patientsupport@umed.io.